J. Gustin

发表

Vesicle--biopolymer gels: networks of surfactant vesicles connected by associating biopolymers.

Tianhong Chen, G. Payne, S. Raghavan, 2005, Langmuir : the ACS journal of surfaces and colloids.

Knockin of mutant PIK3CA activates multiple oncogenic pathways

B. Park, K. Bachman, H. Konishi, 2009, Proceedings of the National Academy of Sciences.

Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells

Hiroyuki Konishi, David Cosgrove, Yuko Konishi, 2011, Proceedings of the National Academy of Sciences.

A PCR-based high-throughput screen with multiround sample pooling: application to somatic cell gene targeting

B. Park, H. Konishi, B. Karakas, 2007, Nature Protocols.

The PIK3CA gene as a mutated target for cancer therapy.

B. Park, J. Gustin, D. Cosgrove, 2008, Current cancer drug targets.

The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation

A. Weeraratna, P. Argani, A. D. De Marzo, 2012, Breast Cancer Research.

Determination of efficacy of a novel alginate dressing in a lethal arterial injury model in swine.

T. Scalea, Matthew B. Dowling, Ian C MacIntire, 2016, Injury.

PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cells

B. Park, H. Konishi, M. Mohseni, 2011, Cancer biology & therapy.

GATA3 frameshift mutation promotes tumor growth in human luminal breast cancer cells and induces transcriptional changes seen in primary GATA3 mutant breast cancers

R. Scharpf, D. Rosen, J. Lauring, 2017, Oncotarget.

Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.

B. Park, K. Bachman, H. Konishi, 2007, Cancer research.

Functional analysis of non-hotspot AKT1 mutants found in human breast cancers identifies novel driver mutations: implications for personalized medicine

Anandita Rajpurohit, Josh Lauring, J. Lauring, 2012, Oncotarget.

The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity.

R. Arceci, B. Park, H. Konishi, 2008, Blood.

PIK3CA and AKT1 Mutations Have Distinct Effects on Sensitivity to Targeted Pathway Inhibitors in an Isogenic Luminal Breast Cancer Model System

Anandita Rajpurohit, D. Rosen, J. Beaver, 2013, Clinical Cancer Research.

Tamoxifen-stimulated growth of breast cancer due to p21 loss

P. Argani, A. D. De Marzo, B. Park, 2008, Proceedings of the National Academy of Sciences.

Hydrophobically modified chitosan gauze: a novel topical hemostat.

T. Scalea, Matthew B. Dowling, M. Narayan, 2017, The Journal of surgical research.

INTEGRATED SYSTEMS AND TECHNOLOGIES 3206 Application of Raman Spectroscopy to Identify Microcalcifications and Underlying Breast Lesions at Stereotactic Core Needle Biopsy

R. Dasari, W. Wick, T. Saga, 2013 .

The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation

A. Weeraratna, P. Argani, A. D. De Marzo, 2012, Breast Cancer Research.

Single copies of mutant KRAS and mutant PIK3CA cooperate in immortalized human epithelial cells to induce tumor formation.

P. Argani, B. Park, H. Konishi, 2013, Cancer research.

Molecular and Cellular Pathobiology Single Copies of Mutant KRAS and Mutant PIK 3 CA Cooperate in Immortalized Human Epithelial Cells to Induce Tumor Formation

P. Argani, B. Park, H. Konishi, 2013 .

Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations

B. Vogelstein, K. Polyak, D. Gorkin, 2010, Oncogene.

p21 gene knock down does not identify genetic effectors seen with gene knock out

A. Weeraratna, B. Park, K. Bachman, 2007, Cancer biology & therapy.

PIK3CA and AKT1 Mutations Have Distinct Effects on Sensitivity to Targeted Pathway Inhibitors in an Isogenic Luminal Breast Cancer Model System

D. Rosen, J. Beaver, J. Lauring, 2013, Clinical Cancer Research.

Pik3ca and Akt1 Mutations Have Distinct Effects on Sensitivity to Targeted Pathway Inhibitors in an Isogenic Luminal Breast Cancer Model System Running Title: Pik3ca and Akt1 Mutant Cells Differ in Drug Sensitivity

J. Beaver, J. Lauring, J. Gustin, 2022 .